Pages that link to "Q67896324"
Jump to navigation
Jump to search
The following pages link to Immunohistochemical c-erbB-2 protooncogene expression and nuclear DNA content in human mammary carcinoma in situ (Q67896324):
Displaying 8 items.
- Molecular chemotherapy for breast cancer (Q33543083) (← links)
- Niche-localized tumor cells are protected from HER2-targeted therapy via upregulation of an anti-apoptotic program in vivo. (Q33767497) (← links)
- Biological features of premalignant disease in the human breast (Q35671149) (← links)
- Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43 (Q37130345) (← links)
- The need for epidemiologic studies of in-situ carcinoma of the breast (Q40445371) (← links)
- Expression of the c-erbB-2 proto-oncogene product and nuclear DNA content in benign and malignant human breast parenchyma (Q67516906) (← links)
- Maintenance of DNA content and erbB-2 alterations in intraductal and invasive phases of mammary cancer (Q71789795) (← links)
- Early breast cancer (Q83172031) (← links)